# RETACRIT
> **BLA125545** · Biologics License Application · Sponsor: HOSPIRA INC · Approved 2018-05-15
## Drug
- **FDA Application Number:** BLA125545
- **Application type:** Biologics License Application
- **Brand name:** RETACRIT
- **Generic name:** EPOETIN ALFA-EPBX
- **Active ingredients:** EPOETIN ALFA-EPBX
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** HOSPIRA INC
- **Manufacturer:** Vifor (International) Inc.
- **First approval:** 2018-05-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125545)
---
*AI Analytics · CC0 1.0*